Your monthly Libtayo cost savings if eligible
The Libtayo patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Libtayo, regardless of the retail price.
Am I eligible for the Libtayo patient assistance program?
To find out if you are eligible for Libtayo assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Libtayo patient assistance program?
Our application process aims to make it as easy as possible to apply for the Libtayo patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Libtayo.
NiceRx will review your application and determine whether you may be eligible for Libtayo assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Libtayo patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Libtayo.
Is NiceRx a Libtayo coupons provider?
NiceRx is a service provider that helps eligible individuals access the Libtayo patient assistance program. We do not offer trial offers or free Libtayo samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Libtayo coupons, discount cards, or Libtayo copay cards.
Can NiceRx help me get Libtayo if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Libtayo medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Libtayo cost without insurance?
Libtayo prices without insurance will vary depending on Libtayo. Prices will also vary by retailer. As a guide, Libtayo intravenous solution (350 mg/7 mL) typically costs $9,845 for a supply of 7 milliliters.
How much does Libtayo cost with insurance?
The copay for Libtayo will vary by the terms of your healthcare plan. To find out what you might need to pay for Libtayo with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Libtayo?
Libtayo is an FDA (Food and Drug Administration) approved cancer immunotherapy manufactured by Regeneron Pharmaceuticals, Inc and Sanofi-Aventis U.S. LLC., for patients above 18 years of age, used as a monotherapy treatment for the following indications:
- metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced cutaneous squamous cell carcinoma (laCSCC) who are not candidates for curative surgery or curative radiation. CSCC is the second most common skin cancer in the U.S.
- locally advanced basal cell carcinoma (laBCC) previously treated with a hedgehog pathway inhibitor (HHI) or for whom an HHI is not appropriate. Patients with locally advanced BCC given the immunotherapy experienced an objective response rate (ORR) of 32%.
- first-line treatment for non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression [tumor proportion score (TPS) ≥50%] as determined by an FDA-approved test, with no EGFR, ALK, or ROS1 aberrations, and is locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or metastatic.
The immune system works by creating antibodies, which are proteins that attach to antigens found on the surface of a cell. The antibody “calls” the immune system to attack the cell it is attached to, resulting in the immune system killing the cell. Monoclonal antibodies are created in a lab to attach to the antigens found on specific types of cancer cells. These antibodies can work in different ways, including stimulating the immune system to kill the cell, blocking cell growth, or other functions necessary for cell growth.
Libtayo (cemiplimab-rwlc) is a type of monoclonal antibody therapy, which works to stimulate the immune system to destroy cancer cells. Cemiplimab-rwlc works as a form of immunotherapy by binding to the “programmed death receptor” (PD1) found on T-cells to stimulate the immune system to find and kill cancer cells.
What doses of Libtayo are available?
Libtayo is available in injection form in the following dose: 350 mg/7 mL (50 mg/mL) solution in a single-dose vial, for intravenous use.
Before administering, visually inspect for particulate matter and discoloration. LIBTAYO is a clear to slightly opalescent, colorless to a pale yellow solution that may contain trace amounts of translucent to white particles. Discard the vial if the solution is cloudy, is discolored, or contains extraneous particulate matter other than trace amounts of translucent to white particles.
To prepare, Withdraw 7 mL from a vial and dilute with 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP to a final concentration between 1 mg/mL to 20 mg/mL. Mix diluted solution by gentle inversion. Do not shake. Allow the diluted solution to come to room temperature prior to administration
The recommended dosage of Libtayo is 350 mg administered as an intravenous infusion (directly into a vein) over 30 minutes every 3 weeks until disease progression or unacceptable toxicity.
Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Libtayo active ingredients
Libtayo is an anti-cancer medicine that contains the active substance cemiplimab, which is a monoclonal antibody.
Libtayo side effects
The most common side effects or adverse reactions caused by Libtayo include:
- Muscle or bone pain
- Pruritus (itching)
In rare instances, Libtayo can cause more serious adverse reactions or side effects. These can include:
- Lung problems: cough, shortness of breath, or chest pain
- Immune-mediated nephritis
- Intestinal problems: diarrhea (loose stools) or more frequent bowel movements than usual, stools that are black, tarry, sticky or have blood or mucus, or severe stomach-area (abdomen) pain or tenderness
- Liver problems: yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea-colored), or bleeding or bruising more easily than normal
- Hormone gland problems: a headache that will not go away or unusual headaches, eye sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or weight loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, dizziness or fainting, or changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness
- Kidney problems: decrease in your amount of urine, blood in your urine, swelling of your ankles, or loss of appetite
- Skin problems: rash, itching, skin blistering or peeling, painful sores or ulcers in mouth or nose, throat, or genital area, fever or flu-like symptoms, or swollen lymph nodes
- Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with Libtayo. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include: chest pain, irregular heartbeat, shortness of breath or swelling of ankles, confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs, double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight, persistent or severe muscle pain or weakness, muscle cramps, low red blood cells, or bruising
- Libtayo can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. These problems may happen anytime during treatment or even after your treatment has ended.
- Infusion reactions can sometimes be severe. Signs and symptoms of infusion reactions may include: nausea, chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feeling like passing out, fever, back or neck pain, or facial swelling
- Immune-mediated hepatitis.
- Rejection of a transplanted organ. Your healthcare provider should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had
- Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with Libtayo. Your healthcare provider will monitor you for these complications
- Thyroid disorders
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with Libtayo. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with Libtayo if you have severe side effects.
Patients are encouraged to report negative side effects or adverse reactions of Libtayo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Libtayo drug interactions
Libtayo can interact with other medications. These include:
This list is not exhaustive and other drugs may interact with Libtayo.
You should not use Libtayo if you:
- Are allergic to the active ingredient Libtayo
- Are allergic to any of the other ingredients in Libtayo
- Are pregnant or are planning to become pregnant (Libtayo can harm your unborn baby)
- Have myasthenia gravis, a skeletal muscle disorder
- Have a type of inflammation of the lung called interstitial pneumonitis
- Have inflammation of the large intestine
- Have liver inflammation resulting from an abnormal immune response
- Have kidney inflammation
- Are a mother who is producing milk and breastfeeding
Talk to your doctor before using Libtayo if you:
- Are taking any of the medications that could interact with Libtayo
- Have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus
- Have received an organ transplant
- Have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
- Have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
Libtayo is the trademark brand name for cemiplimab-rwlc manufactured by Regeneron Pharmaceuticals, Inc. A generic version of Libtayo is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Libtayo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.